CONTEXT: In women with polycystic ovary syndrome (PCOS), excess ovarian androgen production is driven by increased LH secretion. Studies conducted in animals suggest that the granulosa cell may influence LH-stimulated theca cell androgen production. OBJECTIVE: The objective of this study was to determine whether FSH enhances androgen production in women with PCOS compared with that of normal women. DESIGN: A prospective study was conducted to compare androgen production in response to FSH in two groups of women. SETTING: The study was conducted in a General Clinical Research Center in a tertiary academic medical center. PATIENTS: Women with PCOS, 18-35 yr (n = 20), and normal ovulatory controls, 18-35 yr (n = 10), were recruited for study. INTERVENTIONS: Serial blood samples were obtained over a 24-h period after an iv injection of recombinant human FSH (150 IU). MAIN OUTCOME MEASURES: The main outcome measures were serum 17-hydroxyprogesterone (17-OHP), androstenedione (A), dehydroepiandrosterone (DHEA), testosterone (T), and inhibin B (Inh B) responses after FSH administration. RESULTS: Basal serum 17-OHP, A, and T levels were markedly increased in women with PCOS compared with that observed in normal women. Basal DHEA and Inh B levels were similar to those of normal controls. After FSH injection, PCOS women demonstrated enhanced production of 17-OHP, A, DHEA, and Inh B, whereas in normal women no increases were observed. T levels declined slightly in both groups. CONCLUSIONS: These findings provide evidence that, in PCOS women, theca cell androgen production is enhanced by FSH administration and suggest a granulosa-theca cell paracrine mechanism.
CONTEXT: In women with polycystic ovary syndrome (PCOS), excess ovarian androgen production is driven by increased LH secretion. Studies conducted in animals suggest that the granulosa cell may influence LH-stimulated theca cell androgen production. OBJECTIVE: The objective of this study was to determine whether FSH enhances androgen production in women with PCOS compared with that of normal women. DESIGN: A prospective study was conducted to compare androgen production in response to FSH in two groups of women. SETTING: The study was conducted in a General Clinical Research Center in a tertiary academic medical center. PATIENTS: Women with PCOS, 18-35 yr (n = 20), and normal ovulatory controls, 18-35 yr (n = 10), were recruited for study. INTERVENTIONS: Serial blood samples were obtained over a 24-h period after an iv injection of recombinant human FSH (150 IU). MAIN OUTCOME MEASURES: The main outcome measures were serum 17-hydroxyprogesterone (17-OHP), androstenedione (A), dehydroepiandrosterone (DHEA), testosterone (T), and inhibin B (Inh B) responses after FSH administration. RESULTS: Basal serum 17-OHP, A, and T levels were markedly increased in women with PCOS compared with that observed in normal women. Basal DHEA and Inh B levels were similar to those of normal controls. After FSH injection, PCOSwomen demonstrated enhanced production of 17-OHP, A, DHEA, and Inh B, whereas in normal women no increases were observed. T levels declined slightly in both groups. CONCLUSIONS: These findings provide evidence that, in PCOSwomen, theca cell androgen production is enhanced by FSH administration and suggest a granulosa-theca cell paracrine mechanism.
Authors: Paul G Farnworth; Peter G Stanton; Yao Wang; Ruth Escalona; Jock K Findlay; Guck T Ooi Journal: Endocrinology Date: 2006-04-06 Impact factor: 4.736
Authors: J Hofland; F H van Nederveen; M A Timmerman; E Korpershoek; W W de Herder; J W Lenders; A A Verhofstad; R R de Krijger; F H de Jong Journal: Clin Endocrinol (Oxf) Date: 2007-03 Impact factor: 3.478
Authors: S G Hillier; E J Wickings; P I Illingworth; E L Yong; L E Reichert; D T Baird; A S McNeilly Journal: Clin Endocrinol (Oxf) Date: 1991-07 Impact factor: 3.478
Authors: Annie A Guedikian; Alexandria Y Lee; Tristan R Grogan; David H Abbott; Karla Largaespada; Gregorio D Chazenbalk; Daniel A Dumesic Journal: Fertil Steril Date: 2018-02-07 Impact factor: 7.329
Authors: Israel Ortega; Amanda B Cress; Donna H Wong; Jesus A Villanueva; Anna Sokalska; Ben C Moeller; Scott D Stanley; Antoni J Duleba Journal: Biol Reprod Date: 2012-01-30 Impact factor: 4.285
Authors: Bill L Lasley; Sybil L Crawford; Gail A Laughlin; Nanette Santoro; Daniel S McConnell; Carolyn Crandall; Gail A Greendale; Alex J Polotsky; Marike Vuga Journal: Menopause Date: 2011-05 Impact factor: 2.953
Authors: Malinda S Lee; Andrea Lanes; Andrey V Dolinko; Alexandra Bailin; Elizabeth Ginsburg Journal: J Assist Reprod Genet Date: 2020-07-04 Impact factor: 3.412
Authors: Kevin H Maas; Sandy S Chuan; Heidi Cook-Andersen; H Irene Su; A Duleba; R Jeffrey Chang Journal: J Clin Endocrinol Metab Date: 2015-01 Impact factor: 5.958